242
Views
4
CrossRef citations to date
0
Altmetric
Review

The role of cardiopulmonary exercise testing and training in patients with pulmonary hypertension: making the case for this assessment and intervention to be considered a standard of care

, , , &
Pages 317-327 | Received 18 Sep 2019, Accepted 19 Dec 2019, Published online: 03 Jan 2020

References

  • Galiè N, Humbert M, Vachiery J-L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endor. Eur Heart J. 2016;37:67–119.
  • McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association. J Am Coll Cardiol. 2009;53:1573–1619.
  • Naeije R, Chin K. Differentiating precapillary from postcapillary pulmonary hypertension. Circulation. 2019;140:712–714.
  • Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France results from a national registry. Am J Respir Crit Care Med. 2006;173:1023–1030.
  • Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry. Chest. 2010;137:376–387.
  • Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010;122:156–163.
  • Al-Naamani N, Paulus JK, Roberts KE, et al. Racial and ethnic differences in pulmonary arterial hypertension. Pulm Circ. 2017;7:793–796.
  • Tapson VF. The Pulmonary Circulation. In: Klinger JR, Frantz RP, editors. Diagnosis management pulmonary hypertens. Springer New York: New York. 2015. 1–20. DOI:10.1007/978-1-4939-2636-7_1
  • Dunham-Snary KJ, Wu D, Sykes EA, et al. Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine. Chest. 2017;151:181–192.
  • Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53. DOI:10.1183/13993003.01913-2018.
  • Vallerand JR, Weatherald J, Laveneziana P. Pulmonary hypertension and exercise. Clin Chest Med. 2019;40:459–469.
  • Richter MJ, Voswinckel R, Tiede H, et al. Dynamic hyperinflation during exercise in patients with precapillary pulmonary hypertension. Respir Med. 2012;106:308–313.
  • Laveneziana P, Humbert M, Godinas L, et al. Inspiratory muscle function, dynamic hyperinflation and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J. 2015;45:1495–1498.
  • Nootens M, Wolfkiel CJ, Chomka EV, et al. Understanding right and left ventricular systolic function and interactions at rest and with exercise in primary pulmonary hypertension. Am J Cardiol. 1995;75:374–377.
  • Marra AM, Arcopinto M, Bossone E, et al. Pulmonary arterial hypertension-related myopathy: an overview of current data and future perspectives. Nutr Metab Cardiovasc Dis. 2015;25:131–139. Available from: https://www.sciencedirect.com/science/article/pii/S0939475314003135?via%3Dihub
  • Marra AM, Egenlauf B, Bossone E, et al. Principles of rehabilitation and reactivation: pulmonary hypertension. Themat Rev Ser. 2015;89:265–273. Available from: www.karger.com/res
  • Tolle J, Waxman A, Systrom D. Impaired systemic oxygen extraction at maximum exercise in pulmonary hypertension. Med Sci Sports Exercise. 2008;40:3–8.
  • Mainguy V, Maltais F, Saey D, et al. Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax. 2010;65:113–117.
  • Culley MK, Chan SY. Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains. J Clin Invest. 2018;128:3704–3715. Available from: https://www.jci.org/articles/view/120847
  • Marshall JD, Bazan I, Zhang Y, et al. Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both. Am J Physiol Cell Mol Physiol. 2018;314:L782–L796.
  • Balady GJ, Arena R, Sietsema K, et al. Clinician’s guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010;122:191–225. Available from: http://circ.ahajournals.org/cgi/content/long/122/2/191
  • Wensel R, Francis DP, Meyer FJ, et al. Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension. Int J Cardiol. 2013;167:1193–1198.
  • Chen Y-J, Tu H-P, Lee C-L, et al. Comprehensive exercise capacity and quality of life assessments predict mortality in patients with pulmonary arterial hypertension. Acta Cardiol Sin. 2019;35:55–64. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342835/pdf/acs-35-055.pdf
  • Deboeck G, Scoditti C, Huez S, et al. Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension. Eur Respir J. 2012;40:1410–1419.
  • Babu AS, Myers J, Arena R, et al. Evaluating exercise capacity in patients with pulmonary arterial hypertension. Expert Rev Cardiovasc Ther. 2013;11:729–737.
  • Ferreira EVM, Ota-Arakaki JS, Ramos RP, et al. Optimizing the evaluation of excess exercise ventilation for prognosis assessment in pulmonary arterial hypertension. Eur J Prev Cardiol. 2014;21:1409–1419.
  • Ozemek C, Arena R. Cardiopulmonary exercise testing in patients with heart failure and a preserved ejection fraction: filling the prognostic knowledge gap. Rev Esp Cardiol. 2018 Apr;71(4):237-239. DOI: 10.1016/j.rec.2017.08.012
  • Kaminsky LA, Arena R, Ellingsen O, et al. Cardiorespiratory fitness and cardiovascular disease - The past, present, and future. Prog Cardiovasc Dis. 2019;62:86–93.
  • Guazzi M, Bandera F, Ozemek C, et al. Cardiopulmonary exercise testing: what is its value? J Am Coll Cardiol. 2017;70:1618–1636.
  • Cahalin LP, Chase P, Arena R, et al. A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure. Heart Fail Rev. 2013;18:79–94.
  • Arena R, Guazzi M, Myers J, et al. The prognostic utility of cardiopulmonary exercise testing stands the test of time in patients with heart failure. J Cardiopulm Rehabil Prev. 2012;32:198–202.
  • Babu AS, Arena R, Myers J, et al. Exercise intolerance in pulmonary hypertension: mechanism, evaluation and clinical implications. Expert Rev Respir Med. 2016;10:979–990.
  • Arena R, Humphrey R, Peberdy MA. Prognostic ability of VE/VCO2 slope calculations using different exercise test time intervals in subjects with heart failure. Eur J Cardiovasc Prev Rehabil. 2003;10:463–468.
  • Koike A, Itoh H, Kato M, et al. Prognostic power of ventilatory responses during submaximal exercise in patients with chronic heart disease. Chest. 2002;121:1581–1588.
  • Fischer L, Benjamin N, Blank N, et al. Right heart size and function significantly correlate in patients with pulmonary arterial hypertension - a cross-sectional study. Respir Res. 2018;19:216.
  • Nagel C, Marra AM, Benjamin N, et al. Reduced right ventricular output reserve in patients with systemic sclerosis and mildly elevated pulmonary artery pressure. Arthritis Rheumatol. 2019;71:805–816. DOI:10.1002/art.40814
  • Douglas PS, Khandheria B, Stainback RF, et al. ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emerg. J Am Coll Cardiol. 2008;51:1127–1147.
  • Grünig E, Weissmann S, Ehlken N, et al. Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia. Circulation. 2009;119:1747–1757.
  • El-Yafawi R, Rancourt D, Hacobian M, et al. Pulmonary hypertension subjects exhibit right ventricular transient exertional dilation during supine exercise stress echocardiography. Pulm Circ. 2019 Apr-Jun;9(2):2045894019851904.DOI: 10.1177/2045894019851904.
  • Badagliacca R, Papa S, Poscia R, et al. The added value of cardiopulmonary exercise testing in the follow-up of pulmonary arterial hypertension. J Heart Lung Transplant. 2019;38:306–314.
  • Ozemek C, Berry MJ, Arena R. A review of exercise interventions in pulmonary arterial hypertension and recommendations for rehabilitation programing. J Cardiopulm Rehabil Prev. 2019;39:138–145.
  • Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with chronic heart failure delays ventilatory anaerobic threshold and improves submaximal exercise performance. Circulation. 1989;79:324–329.
  • Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects. Circulation. 1988;78:506–515.
  • Ehlken N, Lichtblau M, Klose H, et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial. Eur Heart J. 2016;37:35–44.
  • Chan L, Chin LMK, Kennedy M, et al. Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension. Chest. 2013;143:333–343.
  • Weinstein AA, Chin LMK, Keyser RE, et al. Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respir Med. 2013;107:778–784.
  • Mereles D, Ehlken N, Kreuscher S, et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006;114:1482–1489.
  • Grünig E, Ehlken N, Ghofrani A, et al. Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension. Respiration. 2011;81:394–401.
  • Nagel C, Prange F, Guth S, et al. Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension. PLoS One. 2012;7:e41603.
  • Fox BD, Kassirer M, Weiss I, et al. Ambulatory rehabilitation improves exercise capacity in patients with pulmonary hypertension. J Card Fail. 2011;17:196–200.
  • Pandey A, Garg S, Khunger M, et al. Efficacy and safety of exercise training in chronic pulmonary hypertension. Circ Heart Fail. 2015;8:1032–1043.
  • Yuan P, Yuan X-T, Sun X-Y, et al. Exercise training for pulmonary hypertension: a systematic review and meta-analysis. Int J Cardiol. 2015;178:142–146.
  • Buys R, Avila A, Cornelissen VA. Exercise training improves physical fitness in patients with pulmonary arterial hypertension: a systematic review and meta-analysis of controlled trials. BMC Pulm Med. 2015;15:40.
  • Morris NR, Kermeen FD, Holland AE. Exercise-based rehabilitation programmes for pulmonary hypertension. Cochrane Database Syst Rev. 2017. DOI:10.1002/14651858.CD011285.pub2
  • Grünig E, Eichstaedt C, Barberà J-A, et al. ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension. Eur Respir J. 2019;53:1800332.
  • Saglam M, Arikan H, Vardar-Yagli N, et al. Inspiratory muscle training in pulmonary arterial hypertension. J Cardiopulm Rehabil Prev. 2015;35:198–206.
  • Kabitz H-J, Bremer H-C, Schwoerer A, et al. The combination of exercise and respiratory training improves respiratory muscle function in pulmonary hypertension. Lung. 2014;192:321–328.
  • González-Saiz L, Fiuza-Luces C, Sanchis-Gomar F, et al. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: the WHOLEi+12 trial. Int J Cardiol. 2017;231:277–283.
  • Meyer FJ, Lossnitzer D, Kristen AV, et al. Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension. Eur Respir J. 2005;25:125–130.
  • de Man FS, van Hees HWH, Handoko ML, et al. Diaphragm muscle fiber weakness in pulmonary hypertension. Am J Respir Crit Care Med. 2011;183:1411–1418.
  • Grünig E, Lichtblau M, Ehlken N, et al. Safety and efficacy of exercise training in various forms of pulmonary hypertension. Eur Respir J. 2012;40:84–92.
  • de Man FS, Handoko ML, Groepenhoff H, et al. Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respir J. 2009;34:669–675.
  • Ades PA, Keteyian SJ, Wright JS, et al. Increasing cardiac rehabilitation participation from 20% to 70%: A road map from the million hearts cardiac rehabilitation collaborative. Mayo Clin Proc. 2017;92:234–242.
  • Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2000;161:487–492.
  • Mathai SC, Puhan MA, Lam D, et al. The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186:428–433.
  • Weatherald J, Farina S, Bruno N, et al. Cardiopulmonary exercise testing in pulmonary hypertension. Ann Am Thorac Soc. 2017;14:84–92.
  • Fowler RM, Gain KR, Gabbay E. Exercise intolerance in pulmonary arterial hypertension. Pulm Med. 2012;2012:359204.
  • Batt J, Shadly Ahmed S, Correa J, et al. Skeletal muscle dysfunction in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2013;50:130823100749008.
  • Breda AP, Pereira de Albuquerque AL, Jardim C, et al. Skeletal muscle abnormalities in pulmonary arterial hypertension. Lahm T, editor. PLoS One. 2014;9:e114101.
  • Lewis GD, Bossone E, Naeije R, et al. Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases. Circulation. 2013;128:1470–1479.
  • Nogueira-Ferreira R, Moreira-Gonçalves D, Santos M, et al. Mechanisms underlying the impact of exercise training in pulmonary arterial hypertension. Respir Med. 2018;134:70–78.
  • Ley S, Fink C, Risse F, et al. Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension. Eur Radiol. 2013;23:324–331.
  • Schölzel B, Snijder R, Morshuis W, et al. Clinical worsening after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. Neth Heart J. 2011;19:498–503.
  • Hoeper MM, Markevych I, Spiekerkoetter E, et al. Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Eur Respir J. 2005;26:858LP– 863. Available from: http://erj.ersjournals.com/content/26/5/858.abstract
  • Condliffe R, Kiely DG, Gibbs JSR, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008;177:1122–1127.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.